Racial influence on the prevalence of prostate carcinoma in Brazilian volunteers

International Braz J Urol

Volumn 29, Issue 4, 2003, Pages 300-305

  Paschoalin, Edson L ^a   Martins, Antonio C P ^a   Pastorello, Mônica ^a   Sândis, Kiyoko A ^a   Maciel, Lea M Z ^a   Silvar Jr , Wilson A ^a   Zago, Marcos A ^a   Bessa Jr , José ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Prevalence; Prostate specific antigen; Prostatic neoplasms; Race

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; GENETIC HETEROGENEITY; HUMAN; MALE; NEGRO; PHENOTYPE; PREVALENCE; PROSTATE BIOPSY; PROSTATE CARCINOMA; RACE DIFFERENCE; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0141605835     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382003000400003     Document Type: Article

References (20)

1. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al.: Serum PSA in a community-based population of healthy men: establishment of age-specific reference range. JAMA 1993; 270: 860-4.
2. Kronkad A, Lai H, Lamm SH, Lai S: Mortality in prostate cancer. J Urol. 1996; 156: 1084-91.
3. Myrtle JF, Klimley PG, Ivor IP, Bruni JF: Clinical utility of prostate specific antigen (PSA) in the management of prostate cancer. Hybritec Inc., San Diego, CA, 1986: 1-4.
4. Siegal J, Brawer MK: Prostate Specific Antigen. In: Kaisary AV, Murphy GP, Denis L, Griffiths K (ed.), Text Book of Prostate Cancer, Pathology, Diagnosis and Treatment. London, Martin Dunitz. 1999; pp. 121-41.
5. Gann PJ, Hennekens CH, Stampfer MJ: A prospective evaluation of plasma prostate specific antigen for detection of prostatic cancer. JAMA 1995; 273: 289-94.
6. Arcangeli CG, Ornstein DK, Keeth DW, Andriole GL: Prostate-specific antigen as a screening test for prostate cancer. The United States experience. Urol Clin North Am. 1997; 24: 299-306.
7. Martins AC, Reis RB, Suaid HJ, Maciel LM, Cologna AJ, Falconi RA: Screening for carcinoma of the prostate in volunteers. Int Braz J Urol. 2000; 26: 516-22.
8. Antonopoulos IM, Pompeo AC, El Hayek OR, Sarkis AS, Alfer Jr W, Arap S: Results of prostate cancer screening in non-symptomatic men. Int Braz J Urol. 2001; 27: 227-34.
9. Glina S, Toscano Jr IL, Mello LF, Martins FG, Vieira VL, Damas CG: Results of screening for prostate cancer in a community hospital. Int Braz J Urol. 2001; 27: 235-43.
10. Curtin, PD: The atlantic slave trade: a census. Madson/London, University of Wisconsin Press, 1969.
11. s cluster haplotype predominates among Brazilian blacks. Am J Phys Anthropol. 1992; 88: 295-8.
12. s - globin gene in blacks: The contribution of recurrent mutation or gene conversion or both. Proc Natl Acad Sci USA. 1984; 81: 3853-6.
13. Silva Jr, WA: Genetic Diversity in Afro-Brazilian Populations. Thesis. Ribeirão Preto School of Medicine - USP, 1999 [in Portuguese].
14. Bortolini MC, da Silva-Junior WA, Weimer TA, Zago MA, de Guerra DC, Schneider MP, et al.: Protein and hypervariable tandem repeat diversity in eight African-derived South American populations: inferred relationships do not coincide. Hum Biol. 1998; 70: 443-61.
15. Eskew LA, Bare LR, McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 1997; 157: 199-203.
16. Lewis PO, Zaykin D: Genetic Data Analysis: computer program for the analysis of allelic data. Version 1.0, Internet, GDA Home Page , 1997.
17. Chakraborty R: Gene admixture in human populations: Models and predictions. Am J Phys Anthropol. 1986; 29: 1-5.
18. Fonseca FP, Veneziano DB, Betti RC, Okawa CO: Serum levels of prostate specific antigen in patients screened for prostate cancer. Int Braz J Urol. 2001; 27: 32-6.
19. Cheli CD, Levine R, Cambetas DR, Kolker JD, Roberts SB: Age-related reference ranges for complexed. prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaign. Urology 2002; 60 (Suppl A): 53-9.
20. Taille A, Houlgatte A, Houldellete P, Goluboff ET, Berlizot P, Ricordel I: Influence of free-to-total prostate specific antigen variability on the early diagnosis of prostate cancer: a comparative study of three immunoassays. Br J Urol. 1998; 82: 389-92.